Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

University of Patras1,000 enrolled

Overview

Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

SARS-CoV2 Infection Vaccine Reaction

Interventions

Approved vaccines against Sars-Cov2BIOLOGICAL

Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who voluntarily receive COVID-19 vaccination Exclusion Criteria: * Patients who do not complete their vaccination * Patients who do not provide info on their health status

Locations (1)

University Hospital of Patras

Pátrai, Greece

Outcomes

Primary Outcomes

Antibody titer against Sars-Cov2

Time frame: 0-9 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.